Australian and South African miners are exploring ways to supply coal and metals consumers in Europe scrambling for alternative sources to Russian supply, ...
read more read more there is no one sitting on surplus material," Lawcock said. "It's not like people have volumes sitting there to give out. South Africa's Impala Platinum (IMPJ. J), the world's third-largest producer of PGMs, also said it has limited capacity to plug the gap left by Russia's palladium supplies. read more
As Africa grapples with higher food, energy prices, experts debate whether China can offset negative impacts of Russia-Ukraine conflict on continent.
But Wandile Sihlobo, chief economist at the Agricultural Business Chamber of South Africa, said he didn't think sanctions on Russia would increase China-Africa trade. Countries in North Africa, such as Egypt, Russia’s top Africa trade partner, are expected to especially feel the impact of the sanctions. China, on the other hand, is engaged across the continent through loans and infrastructure investment. “The price of bread is going to go up. Russian activity under President Vladimir Putin expanded rapidly in Africa over the past decade. “African countries are in general trying to increase their agricultural exports to China. South Africa exports a lot to China and Russia … so South African companies may be looking to China to make up for disruptions,” he said.
South Africa's Aspen Pharmacare will start supplying its branded COVID-19 vaccine to African nations by June, its chief executive told Reuters on Wednesday, ...
The company is increasing its vaccine capacity from roughly 450 million doses now to 750 million by February 2023. "I think we want to see where the volumes go sustainably. In November 2020 J&J contracted Aspen to package the COVID-19 vaccine components into final vials, a process called fill and finish, and supply it back to J&J. Under the terms of the deal, Aspen is currently supplying 20 million doses per month to J&J.
South African drugmaker Aspen Pharmacare has announced an agreement with American multinational Johnson & Johnson to package, sell and distribute the ...
The South African pharmaceutical company will sell and distribute the vaccines, under its own packaging, across Africa. The South African pharmaceutical company will sell and distribute the vaccines, under its own packaging, across Africa. South African drugmaker Aspen Pharmacare has announced an agreement with American multinational Johnson & Johnson to package, sell and distribute the latter’s COVID-19 vaccines under its own brand in Africa.
Drawing from its Syria playbook, Russia has propped up proxies in Libya, Central African Republic, Mali and Sudan. Moscow also has its sights on another half ...
This week on Intercepted: Investigative reporter Nick Turse details the U.S. involvement on the African continent. U.S.-trained officers have attempted coups in ...
We don’t have ads, so we depend on our members — 35,000 and counting — to help us hold the powerful to account. How many covert wars, miscarriages of justice, and dystopian technologies would remain hidden if our reporters weren’t on the beat? The Intercept is an independent nonprofit news outlet.
Where to apply for funding for birthright trips from West Africa to Hungary and Croatia.
South Africa's Aspen has clinched its COVID-19 vaccine licensing deal with Johnson & Johnson in a move the company last year said could be a “game-changer” ...
Drawing from its Syria playbook, Russia has propped up proxies in Libya, Central African Republic, Mali and Sudan. Moscow also has its sights on another half ...
This has contributed to the upsurge of coups as well as the use of militaries as a coercive tool against political opponents. This legally prohibits African states from allowing mercenaries into their territory and should be employed to bar Wagner from the continent. Civil society can also heighten scrutiny and transparency of opaque contracts that tend to provide the patronage that props up coopted regimes. It’s reasonable that African governments will want to have multiple external relationships subject to their context and interests. The powerful speech by Kenya’s ambassador to the United Nations, Martin Kimani, in defence of respecting sovereignty, territorial integrity, and resolving differences through non-violent means, epitomises the views of this group and its support for a rules-based order. Third, building the capacity and space of African journalists is especially vital. The African countries that abstained, or did not vote, did so for a variety of reasons. The United Nations’ vote on Russia’s invasion in Ukraine provides a useful prism to understand relationships between Moscow and particular African countries. But I calculated that the median Global Freedom score for this group of 28 countries based on Freedom House’s annual (0-100) ratings is 20 points higher than those that did not vote to condemn. In total, 28 of Africa’s 54 countries voted to condemn the Russian invasion, 16 abstained and 9 did not vote. By and large, they support the upholding of international law to maintain peace and security. Never mind that this diverges wildly from the democratic aspirations held by the vast majority of African citizens.
Janssen has concluded an agreement with South Africa-based company Aspen for the manufacturing and offering of Covid-19 vaccine in Africa.
J&J has so far supplied more than 200 million doses of the vaccine to the continent, under various advance purchase agreements with South Africa, AVAT and Gavi, the Vaccine Alliance, together with donations from the government. The vaccines will be provided to all 55 Member States of the African Union (AU), as well as crucial multilateral entities that back the Covid-19 inoculation campaign in Africa, including the African Vaccine Acquisition Trust (AVAT) and the COVAX Facility. Under the deal, J&J will provide Covid-19 vaccine drug substance to Aspen, which will manufacture and make the finished vaccines available under its own brand name Aspenovax.
JOHANNESBURG (Reuters) -South African drugmaker Aspen Pharmacare on Wednesday reported a 37% rise in interim profit for the half year ending Dec. 31, ...
“We expect a material jump to our annual revenues and profits from next year (on account of Aspenovax),” said CEO Stephen Saad. Its headline earnings per share – the main profit measure in South Africa – was at 777.2 cents ($0.5127) for the half year, up from 566.2 cents posted in the year ago period. JOHANNESBURG (Reuters) -South African drugmaker Aspen Pharmacare on Wednesday reported a 37% rise in interim profit for the half year ending Dec. 31, as its branded medicines division benefited from rising demand during the successive waves of the coronavirus.